Choline magnesium trisalicylate and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Choline magnesium trisalicylate and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: choline salicylate / magnesium salicylate
Brand name: Choline magnesium trisalicylate, Tricosal, Trilisate, CMT
Synonyms: Choline Magnesium Trisalicylate
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Choline magnesium trisalicylate-Insulin glargine, recombinant Subcutaneous
- Choline magnesium trisalicylate-Insulin glulisine
- Choline magnesium trisalicylate-Insulin Glulisine (Cartridges and Pens)
- Choline magnesium trisalicylate-Insulin Glulisine (Vials)
- Choline magnesium trisalicylate-Insulin glulisine Subcutaneous
- Choline magnesium trisalicylate-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Choline Magnesium Trisalicylate Liquid
- Insulin glargine and lixisenatide Subcutaneous-Cholografin Meglumine
- Insulin glargine and lixisenatide Subcutaneous-Chondroitin
- Insulin glargine and lixisenatide Subcutaneous-Chondroitin and glucosamine
- Insulin glargine and lixisenatide Subcutaneous-Chondroitin, glucosamine, and methylsulfonylmethane MSM
- Insulin glargine and lixisenatide Subcutaneous-Chorex